Skip to main content

Table 1 Non-COVID-19 outpatients with thyroid diseases

From: Nonthyroidal illness syndrome (NTIS) in severe COVID-19 patients: role of T3 on the Na/K pump gene expression and on hydroelectrolytic equilibrium

  Hyper Sub (n. 19)
Mean (St. Dev.)
Euthyroid (n. 57)
Mean (St. Dev.)
Hypo Sub (n. 12)
Mean (St. Dev.)
Hypo Overt (n. 7)
Mean (St. Dev.)
Myxedema (n. 1) Total (n. 96)
Mean (St. Dev.)
Sex (F/M) 17/2 50/7 12/0 6/1 0/1 85/11
Age (years) 55.7 (± 14.3) 54.8 (± 14.8) 49.2 (± 17.7) 53.4 (± 20.3) 78 54.4 (± 15.5)
BMI 25.8 (± 5.1) 26.9 (± 5.7) 24.4 (± 6.2) 27.3 (± 9.0) 27.6 26.4 (± 5.9)
FT3 (pg/ml) 3.2 (± 0.8) 2.9 (± 0.4) 2.7 (± 0.5) 2.0 (± 0.6) 1.7 2.9 (± 0.6)
FT4 (ng/dl) 1.4 (± 0.3) 1.2 (± 0.3) 1.1 (± 0.3) 1.3 (± 1.1) 0.4 1.2 (± 0.4)
TSH (μIU/ml) 0.1 (± 0.1) 1.7 (± 0.8) 6.3 (± 1.7) 22.1 (± 10.1) 100.0 4.5 (± 11.6)